Skip to main content
OpenTrials

Clinical trial condition

Recurrent Glioma

Explore clinical trials studying Recurrent Glioma. Study availability and eligibility vary by location and protocol.

23 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Glioma trial results

Recruiting

A Study of GNC-039, a Tetra-specific Antibody, in Participants With Relapsed/Refractory or Metastatic Solid Tumors

NCT04794972

Conditions
Glioma, Neoplasms, Neoplasms by Histologic Type, +7 more
Locations
  • Beijing Tiantan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Affiliated Cancer Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • ZhuJiang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Shenzhen Second People's Hospital Shenzhen, Guangdong, China
View Trial Details
Active, not recruiting

Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations

NCT03212274

Conditions
Adenocarcinoma, Advanced Malignant Solid Neoplasm, Astrocytoma, +16 more
Locations
  • UC Irvine Health Cancer Center-Newport Costa Mesa, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
View all 51 locations
View Trial Details
Active, not recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

NCT02465060

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
View all 1410 locations
View Trial Details
Active, not recruiting

Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment

NCT05859334

Conditions
Glioma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach, Florida, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
View all 27 locations
View Trial Details

Related conditions